An independent review of Persona Nutrition's supplement recommendations, outcomes data, predictive accuracy, and consumer complaint signals. Includes BBB, FDA, and clinical context.
A clinical breakdown of which patients should not use Prime Mind's cash-pay ADHD and cognition telehealth platform, including safety flags, regulatory standing, and provider questions to ask before enrolling.
An independent review of Ro telehealth's prescribing patterns, compounding practices, patient outcomes signals, complaint records, and regulatory standing across GLP-1, ED, hair loss, and mental health services.
A critical, evidence-based look at Ro's pricing history across GLP-1, ED, hair loss, and mental health programs, including compounding cost shifts, FDA actions, and real patient cost data from 2018 to 2025.
A clinical breakdown of which patients should avoid Ro's telehealth platform, covering GLP-1, ED, hair loss, and mental health services, with independent analysis of legitimacy, complaints, and safety concerns.
An independent review of Seed Health's DS-01 probiotic, examining published clinical data, regulatory standing, consumer complaints, and what prescribers should know before recommending it.
A critical, evidence-based look at which patients should avoid Shapiro MD hair-loss products, whether the brand is legitimate, and what the complaints reveal about real-world outcomes.
An independent, evidence-based review of Signos's medical leadership, clinical credentials, regulatory standing, and CGM-based weight-loss science. prepared by the HealthRX.com Editorial Team.
An independent review of Strut Health's LegitScript status, state pharmacy board standing, FDA compliance posture, BBB rating, and patient complaint history. prepared by the HealthRX.com Editorial Team.
An evidence-based, independent review of Strut Health's medical leadership, prescriber credentials, compounding pharmacy oversight, and regulatory standing. prepared by the HealthRX.com Editorial Team.
An independent review of Strut Health's prescribing patterns, compounding practices, patient outcomes signals, complaint data, and regulatory standing. prepared by the HealthRX.com Editorial Team.
An independent look at Strut Health's pricing history, fee structure, and value compared to competitors. Includes consultation costs, compounded medication prices, and red flags to watch.
An independent, evidence-based review of Superpower's Better Business Bureau rating, consumer complaints, regulatory standing, and what prospective patients should know before subscribing.
An independent review of Superpower's LegitScript status, state pharmacy board standing, BBB complaints, FDA compliance, and what each signal means for patients considering this telehealth platform.
An independent, evidence-based review of Superpower's medical leadership, physician credentials, regulatory standing, and clinical protocols for GLP-1, peptide, and lab-based concierge care.
An independent clinical review of Superpower's prescribing patterns, GLP-1 and peptide protocols, lab-monitoring standards, and real-world outcomes signals. Includes BBB data, FDA warning context, and a decision framework for prospective patients.
An independent clinical review of Superpower's lab, GLP-1, and peptide subscription service. Learn which patient profiles should avoid it, what the complaints reveal, and whether it is legit.
An independent review of The Blue Zone's BBB standing, consumer complaints, regulatory signals, and what prospective patients should check before enrolling in a cash-pay longevity or peptide program.
An independent review of The Blue Zone telehealth brand's LegitScript status, state licensing, FDA compliance, and BBB record. Find out what verification checks to run before using any cash-pay peptide or longevity clinic.
An evidence-based, critical review of The Blue Zone telehealth brand's medical leadership, physician credentials, regulatory standing, and patient complaint history. prepared by the HealthRX.com Editorial Team.
An independent, evidence-based analysis of The Blue Zone telehealth brand's prescribing practices, peptide protocols, longevity claims, and available outcomes data. prepared by the HealthRX.com Editorial Team.
An independent review of Thirty Madison's LegitScript certification, state pharmacy licensing, BBB rating, FDA compliance, and patient complaints across its Keeps, Cove, Ro, and other D2C brands.
An independent analysis of Thorne's Better Business Bureau rating, consumer complaint patterns, FDA warning letters, and third-party verification status to help you decide whether this supplement brand is trustworthy.
An independent review of Thrive Cause's pricing history, cost trajectory, legitimacy signals, and complaint patterns for compounded peptide therapies. prepared by the HealthRX.com Editorial Team.
An independent review of Thrive Causemetics BBB ratings, FTC complaint patterns, FDA cosmetic-adverse-event data, and verified customer grievances, with primary-source citations throughout.
An independent, evidence-based review of Thrive Causemetics' medical leadership, ingredient credentials, regulatory standing, and consumer complaint history. prepared by the HealthRX.com Editorial Team.
A critical, evidence-based review of Thrive Causemetics ingredients, safety signals, BBB complaints, FDA status, and which patient profiles should avoid the brand's products.
An evidence-based, independent analysis of TrimRx complaint trends on the BBB, FDA databases, and state pharmacy boards. Learn what the data actually show before you subscribe.
An independent look at TrimRx's compounded GLP-1 pricing history, cost trajectory, and what the FDA regulatory environment means for future costs. prepared by the HealthRX.com Editorial Team.
A critical, evidence-grounded look at Truepill's B2B pharmacy infrastructure, the patient profiles most at risk, documented complaints, and how to verify any telehealth platform that dispenses through it.
An independent, evidence-based look at Twenty-Eight Health's prescribing practices, outcomes signals, complaint history, and legitimacy for reproductive health telehealth.
An independent review of Viome's Better Business Bureau rating, consumer complaint patterns, FDA regulatory status, and what telehealth patients should know before buying a microbiome test kit.
Not every patient is a good candidate for Viome's microbiome testing and personalized supplements. Learn which profiles should skip it, what the complaints reveal, and whether Viome is legit by clinical standards.
An independent review of Willow telehealth's BBB rating, consumer complaint patterns, FDA registration status, and LegitScript standing for women seeking GLP-1 and hormone therapy online.
An independent review of Winona telehealth HRT prescribing patterns, available outcomes data, regulatory standing, and patient complaint signals. prepared by the HealthRX.com Editorial Team.
An independent look at Wisp telehealth's BBB rating, verified consumer complaints, regulatory standing, and how its complaint profile compares to other cash-pay sexual-health platforms.
An independent, evidence-based review of Wisp telehealth's medical leadership, licensing, prescribing credentials, complaint history, and how it compares to regulatory benchmarks for legitimate online pharmacies.
An independent look at Wisp telehealth pricing over time, complaint patterns, legitimacy signals, and what cash-pay sexual health care costs in 2025. prepared by the HealthRX.com Editorial Team.
An independent, clinically critical review of Wisp telehealth. Covers who should not use Wisp for sexual health, UTI, or BV treatment, plus legitimacy, complaints, and when to seek in-person care instead.
An evidence-based, independent review of Women's International Pharmacy's medical leadership, compounding credentials, regulatory standing, and BHRT safety record. prepared by the HealthRX.com Editorial Team.
A clinically grounded breakdown of the Winona ideal patient profile, what it prescribes, how it compares to alternatives, and what the evidence says about telehealth menopause HRT.
A clinical review of Women's International Pharmacy's prescription intake process, compounded bioidentical hormone therapy offerings, costs, legitimacy, and how it stacks up against alternatives.
A breakdown of the best ZOE alternatives for personalized nutrition, CGM monitoring, gut microbiome testing, and metabolic health, with cited evidence and real cost comparisons.
Complete clinical guide to bremelanotide (Vyleesi) dosing for young adults aged 18 to 29, including injection technique, timing, side-effect management, and RECONNECT trial data.
A guide to bremelanotide (Vyleesi) safety in women ages 18 to 29, covering nausea rates, blood pressure effects, contraceptive interactions, fertility considerations, and dosing from the RECONNECT trials.
A clinician-level review of bremelanotide (Vyleesi) safety and efficacy in patients with autoimmune conditions, including lupus, RA, MS, and Sjögren syndrome, with primary-literature citations.
A clinical deep-dive into bremelanotide (Vyleesi) and cognitive function. Learn what the RECONNECT trials found, what melanocortin receptors have to do with cognition, and what patients should expect.
An evidence-based comparison of compounded bremelanotide and FDA-approved Vyleesi for HSDD, covering pharmacology, safety, efficacy data from RECONNECT, dosing, and how to choose between options.
A clinical deep-dive into bremelanotide (Vyleesi) hair and skin changes, including transient hyperpigmentation, flushing mechanisms, melanocortin pharmacology, and what the RECONNECT trial data actually show.
A clinician-level review of bremelanotide (Vyleesi) and liver function impact, covering hepatotoxicity data from RECONNECT, ALT/AST monitoring thresholds, and FDA labeling requirements for premenopausal women with HSDD.
A breakdown of bremelanotide's (Vyleesi) effects on mood, anxiety, depression, and emotional well-being, drawn from the RECONNECT trials and post-market safety data.
Evidence-based guidance on safely restarting bremelanotide (Vyleesi) after acute illness, including dose timing, contraindications, and pharmacology from the RECONNECT trial and FDA prescribing information.
A guide to cardiometabolic conditions in pregnancy, covering gestational diabetes management, GLP-1 receptor agonist safety, glucose targets, and long-term cardiovascular risk after delivery.
A guide to spironolactone for blood pressure control, including how it compares with atorvastatin, rosuvastatin, simvastatin, and ezetimibe in a full cardiometabolic treatment plan.
Diplo has spoken openly about testosterone replacement therapy. Here is what his protocol likely looks like, what it costs at the concierge level, and what a regular patient pays for the same clinical outcome.
A clinical guide to tadalafil dosing in adolescents aged 12-17, covering FDA-approved indications, off-label use, safety data, monitoring requirements, and prescribing considerations for pediatric and adolescent patients.
An evidence-based breakdown of every clinically significant drug-drug interaction for tadalafil (Cialis), including nitrates, alpha-blockers, CYP3A4 inhibitors, antihypertensives, and more. Includes mechanisms, clinical thresholds, and management guidance.
A deep dive into tadalafil safety during pregnancy and breastfeeding, covering FDA classification, animal data, placental transfer, PDE5 physiology in pregnancy, and clinical decision-making for women who take Cialis for PAH or other indications.
Evidence-based guide to tadalafil (Cialis) dosing adjustments in chronic kidney disease and dialysis, including mechanism of action, pharmacokinetics, and safety data with PubMed-cited references.
A physician-level review of tadalafil's effects on bone density and bone metabolism, covering PDE5 inhibition mechanisms, preclinical and clinical evidence, fracture risk data, and practical guidance for men on long-term Cialis therapy.